Abstract
The first case of cavitary pulmonary disease caused by Purpureocillium lilacinum is described. The isolate showed atypical microscopic characteristics similar to Acremonium and Fusarium spp., which necessitated molecular identification by sequencing of multiple conserved loci. The patient responded to voriconazole, reinforcing its therapeutic efficacy for P. lilacinum infections.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1800-1804 |
| Number of pages | 5 |
| Journal | Journal of Clinical Microbiology |
| Volume | 50 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2012 |
Fingerprint
ASJC Scopus subject areas
- Microbiology (medical)
Cite this
Purpureocillium lilacinum as a cause of cavitary pulmonary disease : A new clinical presentation and observations on atypical morphologic characteristics of the isolate. / Khan, Ziauddin; Ahmad, Suhail; Al-Ghimlas, Fahad; Al-Mutairi, Sana; Joseph, Leena; Chandy, Rachel; Sutton, Deanna A.; Guarro, Josep.
In: Journal of Clinical Microbiology, Vol. 50, No. 5, 05.2012, p. 1800-1804.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Purpureocillium lilacinum as a cause of cavitary pulmonary disease
T2 - A new clinical presentation and observations on atypical morphologic characteristics of the isolate
AU - Khan, Ziauddin
AU - Ahmad, Suhail
AU - Al-Ghimlas, Fahad
AU - Al-Mutairi, Sana
AU - Joseph, Leena
AU - Chandy, Rachel
AU - Sutton, Deanna A.
AU - Guarro, Josep
PY - 2012/5
Y1 - 2012/5
N2 - The first case of cavitary pulmonary disease caused by Purpureocillium lilacinum is described. The isolate showed atypical microscopic characteristics similar to Acremonium and Fusarium spp., which necessitated molecular identification by sequencing of multiple conserved loci. The patient responded to voriconazole, reinforcing its therapeutic efficacy for P. lilacinum infections.
AB - The first case of cavitary pulmonary disease caused by Purpureocillium lilacinum is described. The isolate showed atypical microscopic characteristics similar to Acremonium and Fusarium spp., which necessitated molecular identification by sequencing of multiple conserved loci. The patient responded to voriconazole, reinforcing its therapeutic efficacy for P. lilacinum infections.
UR - http://www.scopus.com/inward/record.url?scp=84859980372&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84859980372&partnerID=8YFLogxK
U2 - 10.1128/JCM.00150-12
DO - 10.1128/JCM.00150-12
M3 - Article
C2 - 22322350
AN - SCOPUS:84859980372
VL - 50
SP - 1800
EP - 1804
JO - Journal of Clinical Microbiology
JF - Journal of Clinical Microbiology
SN - 0095-1137
IS - 5
ER -